Group One Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-28,300
Closed -$5.2M 9147
2021
Q2
$5.2M Sell
28,300
-11,700
-29% -$2.01M 0.01% 1655
2021
Q1
$6.12M Sell
40,000
-356,000
-90% -$55.1M 0.01% 1339
2020
Q4
$61.9M Buy
396,000
+85,300
+27% +$11M 0.11% 142
2020
Q3
$35.6M Buy
310,700
+78,100
+34% +$8.43M 0.11% 142
2020
Q2
$26.1M Buy
232,600
+22,100
+10% +$2.35M 0.12% 152
2020
Q1
$18.9M Buy
210,500
+145,800
+225% +$14.3M 0.15% 108
2019
Q4
$7M Sell
64,700
-47,200
-42% -$5.05M 0.05% 504
2019
Q3
$11M Buy
111,900
+66,800
+148% +$7.53M 0.09% 247
2019
Q2
$5.91M Buy
45,100
+38,000
+535% +$4.9M 0.05% 429
2019
Q1
$960K Sell
7,100
-14,000
-66% -$1.74M 0.01% 1439
2018
Q4
$2.05M Buy
21,100
+8,800
+72% +$1.04M 0.02% 1022
2018
Q3
$1.71M Sell
12,300
-16,400
-57% -$2.06M 0.01% 1278
2018
Q2
$3.56M Sell
28,700
-177,700
-86% -$20.8M 0.03% 730
2018
Q1
$23M Buy
206,400
+176,500
+590% +$21.1M 0.23% 71
2017
Q4
$3.58M Sell
29,900
-82,600
-73% -$10.1M 0.03% 827
2017
Q3
$15.8M Sell
112,500
-2,800
-2% -$380K 0.14% 140
2017
Q2
$14M Buy
115,300
+109,600
+1,923% +$12.8M 0.15% 143
2017
Q1
$691K Sell
5,700
-12,700
-69% -$1.64M 0.01% 1617
2016
Q4
$2.25M Buy
+18,400
New +$2.25M 0.02% 853

Other funds holding ALXN